Director Clinical Safety
Clinical Safety & Pharmacovigilance, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
Dr. Abdul Waheed Rajper is a physician with over eight years of experience in global drug safety and clinical development. He currently serves as the Global Safety Physician Lead at Daiichi Sankyo, overseeing oncology programs and the REMS strategy for Turalio® (pexidartinib). His expertise spans early-phase trials, signal detection, regulatory strategy, and cross-functional leadership. Dr. Rajper holds an MD from Liaquat Medical University and advanced credentials in clinical research and pharmacovigilance from Northwestern and Loyola Universities. He is passionate about advancing innovative therapies and ensuring patient safety worldwide.
